Thermo Fisher Scientific has signed an agreement with Mainz Biomed to develop and launch a next-generation colorectal cancer ...

Thermo Fisher Scientific Inc. ( NYSE:TMO ) shareholders might be concerned after seeing the share price drop 10% in ...

Thermo Fisher Scientific has good revenue and margin growth prospects ahead and is trading at a discount. See why TMO stock ...

As of 2024-11-13, Thermo Fisher Scientific Inc's intrinsic value as calculated by the Discounted Earnings model is $670.00.

Shares of Thermo Fisher Scientific Inc. TMO slid 1.13% to $540.75 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.29% to ...

The medical device maker has completed more than 40 acquisitions in recent years, helping turn it into one of the state’s ...

Thermo Fisher Scientific has signed an agreement with German molecular genetics company Mainz Biomed, the developer of ...

In a bid to streamline viral vector manufacturing, Thermo Fisher is charting another round of layoffs this year—and ...

Thermo Fisher Scientific (NYSE:TMO) is closing a facility as part of a shift in operations across Massachusetts.

at a negative CAGR of 42.8% from 2024 through 2029. European Life Science Tools and Reagents Market Scope Full List of Company Profiles Included in this Report: ...

the company highlighted applications of the technology in the context of neurodegenerative disease, cancer, and metabolic ...